Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid
Niki S M Schoonenboom1, Cees Mulder, Hugo Vanderstichele
1Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. niki.schoonenboom@vumc.nl
Clinical Chemistry
|April 23, 2005
Abstract
No abstract available in PubMed .
More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
